Oscar Health, Inc. (NYSE:OSCR – Get Rating) has been given an average recommendation of “Hold” by the seven research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $10.04.
A number of research firms have recently commented on OSCR. Morgan Stanley reduced their price objective on shares of Oscar Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Monday, March 28th. Bank of America lowered shares of Oscar Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $12.00 to $6.00 in a research note on Thursday. Finally, Zacks Investment Research raised shares of Oscar Health from a “hold” rating to a “buy” rating and set a $5.75 price objective on the stock in a research note on Friday.
OSCR opened at $5.07 on Friday. The company’s 50 day moving average price is $7.80 and its two-hundred day moving average price is $8.01. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.20 and a quick ratio of 1.20. Oscar Health has a fifty-two week low of $4.48 and a fifty-two week high of $29.70. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of -1.89 and a beta of 0.75.
In other Oscar Health news, EVP Alessandrea C. Quane sold 11,638 shares of the company’s stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $8.30, for a total transaction of $96,595.40. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 19,204 shares of the company’s stock in a transaction on Tuesday, March 8th. The stock was sold at an average price of $7.33, for a total transaction of $140,765.32. The disclosure for this sale can be found here. Insiders have sold a total of 40,557 shares of company stock worth $304,575 in the last quarter.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Advisor Group Holdings Inc. raised its holdings in shares of Oscar Health by 116.8% in the fourth quarter. Advisor Group Holdings Inc. now owns 3,924 shares of the company’s stock valued at $30,000 after purchasing an additional 2,114 shares during the last quarter. Aquire Wealth Advisors LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at about $34,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in shares of Oscar Health in the fourth quarter valued at about $47,000. National Bank of Canada FI purchased a new stake in shares of Oscar Health in the first quarter valued at about $80,000. Finally, Arizona State Retirement System purchased a new stake in shares of Oscar Health in the fourth quarter valued at about $91,000. Hedge funds and other institutional investors own 98.65% of the company’s stock.
Oscar Health Company Profile (Get Rating)
Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.
- Get a free copy of the StockNews.com research report on Oscar Health (OSCR)
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.